动物 API (API) 市场：按治疗类别、合成类型、合同外包类型、药物类型分类——到 2032 年的全球预测

在宠物保险需求不断增长的推动下，预计到 2032 年，全球动物 API (API) 市场将显着增长。

例如，据一位消息人士透露，2021 年美国投保的宠物总数将达到 390 万隻，比 2020 年增长 28%。

预计到 2032 年，宠物保险行业政府举措的增加也将刺激市场需求。 例如，在 2019 年，NAIC 接受了一项製定示范法的请求，以解决诸如报销福利、预先存在的条件、定义、违规、生产者许可证、披露和与宠物保险相关的法规等问题。

在另一个例子中，动物健康和兽医信息的权威来源 VETMED 发布了动物原料药 (API)，宣布将对（成分）的环境发生进行量化。 VETMED 表示，这笔交易将使其能够更好地了解这些药物的重要性。

总体而言，全球兽用 API (API) 市场按治疗类别、合成、合同外包、药物和区域进行细分。

根据治疗类别，市场预计将以非甾体抗炎药细分市场为特征，该细分市场在 2022 年的估值将超过 56 亿美元。 非甾体抗炎药越来越多地用于控制动物的疼痛、发烧和其他炎症迹象。 一项研究证实，英国兽医通常使用 NSAIDs（非甾体抗炎药）来治疗狗的骨关节炎。

基于合成，生物原料药部门将在 2022 年占超过 107 亿美元的收入份额，并在未来十年实现强劲增长。 该细分市场的扩张是由于对用于诊断和治疗动物各种健康问题的生物活性物质的需求不断增长。 此外，属于治疗药物类别的疾病数量正在增加，这将是细分市场扩张的推动力。

基于合同外包，CDMO 部分将在 2023 年至 2032 年间显着增长。 由于 CDMO 为动物 API 提供的优势和好处，这导致了更多的采用。

在医药领域，处方药领域预计将从 2023 年到 2032 年显着增长。 该细分市场的增长预计将受到各种处方药和治疗药物（如抗感染药、非甾体抗炎药、抗生素和治疗严重疾病的疫苗）使用量激增的推动。

按地区划分，由于人畜共患疾病流行的加剧和有利的国家监管情景，全球动物原料药 (API) 市场预计将在北美强劲增长。

内容

第 1 章研究方法和范围

第 2 章执行摘要

第 3 章：动物 API (API) 的行业洞察

• 按行业细分
• 行业格局，2018-2032 年版
• 影响行业的因素
  • 司机
    • 对宠物保险的需求不断增长
    • 提高了对动物健康和身心健康的认识
    • 对畜产品的需求增加
    • 积极的政府举措
    • 饲养宠物
  • 行业潜在的风险和挑战
    • 自付费用较低的兽医费用
    • 兽药成本高
• 增长分析
  • 按治疗类别
  • 按合成类型
  • 按合同外包类型
  • 按药物类型
• COVID-19 影响分析
• 技术概况
• 供应链分析
• 主要市场趋势
• 管道解析
• 监管状况
  • 美国
  • 欧洲
  • 亚太地区
• 供应商矩阵分析
• 波特分析
• PESTEL 分析

第 4 章竞争格局，2021 年

• 简介
• 2021 年公司矩阵分析
• 战略仪表板，2021 年

第 5 章动物 API 市场：按治疗类别分类

• 主要细分趋势
• 抗感染药
• 抗寄生虫药
• 非甾体抗炎药
• 生物製剂
• 其他

第 6 章动物 API 市场：按合成类型

• 主要细分趋势
• 化学原料药
• 生物原料药
• 高活性 API (HPAPI)

第 7 章动物 API (API) 市场：按合同外包类型

• 主要细分趋势
• CDMO
• 首席营销官

第 8 章动物 API 市场：按药物类型分类

• 主要细分趋势
• 处方
• 场外交易

第 9 章动物原料药 (API) 市场：按地区

• 主要区域趋势
• 北美
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 意大利
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳大利亚
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋

第十章公司简介

• Alivira Animal Health Ltd
• SUANFARMA
• Procyon Life Sciences
• Jiangsu Lingyun Pharmaceutical Co., Ltd
• Ofichem Group
• NGL Fine-Chem Ltd
• Huvepharma
• Excel Veterinary Healthcare
• Menadiona
• Indukern Group
• Vetpharma（Insud Pharma）
• Qilu Pharmaceutical（Inner Mongolia）Co., Ltd

Global Veterinary Active Pharmaceutical Ingredients Market is poised to grow significantly through 2032, owing to the increasing demand for pet insurance. For instance, according to a source, the total number of pets that were insured in the U.S. in 2021 was 3.9 million, depicting an increase of 28% from 2020.

Besides, an upsurge in favorable government initiatives in the pet insurance industry will fuel the market demand by 2032. To cite an instance, the NAIC in 2019 accepted the request for Model Law development to address issues such as reimbursement benefits, pre-existing conditions, definitions, violations, producer licensing, disclosures, and regulations regarding pet insurance.

In another instance, VETMED, a reliable source for animal health and veterinary medicine announced quantifying the environmental occurrence of veterinary active pharmaceutical ingredients to better understand the scope of active pharmaceutical ingredients and the spreading of antimicrobial resistance. VETMED claims that the deal will help it to better understand the significance of these medications.

Overall, the global veterinary active pharmaceutical ingredients market is segmented in terms of therapeutic category, synthesis, contract outsourcing, drug, and region.

Based on the therapeutic category, the market is likely to be characterized by the NSAIDs segment, which held a valuation of more than USD 5.6 billion in 2022. NSAIDs are increasingly used to control pain, fever, and other signs of inflammation in animals. A study observed that NSAIDs (Non-steroidal anti-inflammatory drugs) are commonly used to treat canine osteoarthritis by veterinary surgeons in the UK.

Based on synthesis, the biological API segment held more than USD 10.7 billion revenue share in 2022 and will grow robustly over the next ten years. The segmental expansion can be credited to the growing demand for biologically active substances which are used to diagnose and treat various health issues among animals. Besides, there is a rise in the number of diseases in the therapeutic category, which will drive segmental expansion.

On the basis of contract outsourcing, the CDMO segment will grow significantly through 2023-2032, owing to the benefits and advantages offered by them to the veterinary APIs, resulting in their increasing adoption.

In the context of the drug, the prescription segment will grow significantly between 2023 and 2032. The growth of this segment is anticipated to be driven by the surging usage of a range of prescribed medications and therapeutics including anti-infectives, NSAIDs, antibiotics, and vaccines, to treat severe ailments.

In the regional context, the global veterinary active pharmaceutical ingredients market will grow significantly in North America, due to the growing prevalence of zoonotic diseases and a favorable State-backed regulatory scenario.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Industry coverage
• 1.2 Market scope & definitions
• 1.3 Base estimates & working
  • 1.3.1 Data collection
• 1.4 Forecast parameters
• 1.5 COVID-19 impact analysis at global level
• 1.6 Data validation
• 1.7 Data sources
  • 1.7.1 Primary
  • 1.7.2 Secondary
    • 1.7.2.1 Paid sources
    • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Veterinary active pharmaceutical ingredients industry 360 degree synopsis, 2018 - 2032
• 2.2 Business trends
  • 2.2.1 Therapeutic category trends
  • 2.2.2 Synthesis type trends
  • 2.2.3 Contract outsourcing type trends
  • 2.2.4 Drug type trends
  • 2.2.5 Regional trends

Chapter 3 Veterinary Active Pharmaceutical Ingredients Industry Insights

• 3.1 Industry segmentation
• 3.2 Industry landscape, 2018 - 2032
• 3.3 Industry impact forces
  • 3.3.1 Growth drivers
    • 3.3.1.1 Increasing demand for pet insurance
    • 3.3.1.2 Surging awareness of animal health, physical and mental well-being
    • 3.3.1.3 Increasing demand for animal products
    • 3.3.1.4 Favorable government initiatives
    • 3.3.1.5 Growing pet adoption
  • 3.3.2 Industry pitfalls & challenges
    • 3.3.2.1 Low out of pocket expenditure on veterinary care
    • 3.3.2.2 High cost of veterinary medicines
• 3.4 Growth potential analysis
  • 3.4.1 By therapeutic category
  • 3.4.2 By synthesis type
  • 3.4.3 By contract outsourcing type
  • 3.4.4 By drug type
• 3.5 COVID-19 impact analysis
• 3.6 Technology landscape
• 3.7 Supply chain analysis
• 3.8 Key market trends
• 3.9 Pipeline analysis
• 3.10 Regulatory landscape
  • 3.10.1 U.S.
  • 3.10.2 Europe
  • 3.10.3 Asia Pacific
• 3.11 Vendor matrix analysis
• 3.12 Porter's analysis
  • 3.12.1 Industry rivalry
  • 3.12.2 Bargaining power of suppliers
  • 3.12.3 Bargaining power of buyers
  • 3.12.4 Threat of substitute
  • 3.12.5 Threat of new entrants
• 3.13 PESTEL analysis
  • 3.13.1 Political
  • 3.13.2 Economical
  • 3.13.3 Social
  • 3.13.4 Technological
  • 3.13.5 Legal
  • 3.13.6 Environmental

Chapter 4 Competitive Landscape, 2021

• 4.1 Introduction
• 4.2 Company matrix analysis, 2021
• 4.3 Strategy dashboard, 2021

Chapter 5 Veterinary Active Pharmaceutical Ingredients Market, By Therapeutic Category

• 5.1 Key segment trends
• 5.2 Anti-infectives
  • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 5.3 Anti-parasitic
  • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 5.4 NSAIDs
  • 5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 5.5 Biologics
  • 5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 5.6 Others
  • 5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 Veterinary Active Pharmaceutical Ingredients Market, By Synthesis Type

• 6.1 Key segment trends
• 6.2 Chemical based API
  • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 6.3 Biological API
  • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 6.4 Highly potent API (HPAPI)
  • 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Veterinary Active Pharmaceutical Ingredients Market, By Contract Outsourcing Type

• 7.1 Key segment trends
• 7.2 CDMO
  • 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 7.3 CMO
  • 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8 Veterinary Active Pharmaceutical Ingredients Market, By Drug Type

• 8.1 Key segment trends
• 8.2 Prescription
  • 8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 8.3 OTC
  • 8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9 Veterinary Active Pharmaceutical Ingredients Market, By Region

• 9.1 Key regional trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East & Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Alivira Animal Health Ltd
• 10.2 SUANFARMA
• 10.3 Procyon Life Sciences
• 10.4 Jiangsu Lingyun Pharmaceutical Co., Ltd
• 10.5 Ofichem Group
• 10.6 NGL Fine-Chem Ltd
• 10.7 Huvepharma
• 10.8 Excel Veterinary Healthcare
• 10.9 Menadiona
• 10.10 Indukern Group
• 10.11 Vetpharma (Insud Pharma)
• 10.12 Qilu Pharmaceutical (Inner Mongolia) Co., Ltd

Data Tables

• TABLE 1. Product mapping
• TABLE 2. Market revenue, by therapeutic category (2022)
• TABLE 3. Market revenue, by synthesis type (2022)
• TABLE 4. Market share, by contract outsourcing type (2022)
• TABLE 5. Market share, by drug type (2022)
• TABLE 6. Market share, by region (2022)
• TABLE 7. Global veterinary active pharmaceutical ingredients market, 2018 - 2024 (USD Million)
• TABLE 8. Global veterinary active pharmaceutical ingredients market, 2025 - 2032 (USD Million)
• TABLE 9. Global veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024 (USD Million)
• TABLE 10. Global veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032 (USD Million)
• TABLE 11. Global veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 12. Global veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 13. Global veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024 (USD Million)
• TABLE 14. Global veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032 (USD Million)
• TABLE 15. Global veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024 (USD Million)
• TABLE 16. Global veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032 (USD Million)
• TABLE 17. Global veterinary active pharmaceutical ingredients market, 2018 - 2024 (USD Million)
• TABLE 18. Global veterinary active pharmaceutical ingredients market, 2025 - 2032 (USD Million)
• TABLE 19. Industry impact forces
• TABLE 20. Comprehensive study of active pharmaceutical ingredients supply chain of the U.S. and Europe
• TABLE 21. Veterinary APIs under development for the manufacturing of animal drugs
• TABLE 22. Application of GMP guidance to API manufacturing
• TABLE 23. Anti-infectives market, 2018 - 2024 (USD Million)
• TABLE 24. Anti-infectives market, 2025 - 2032 (USD Million)
• TABLE 25. Anti-parasitic market, 2018 - 2024 (USD Million)
• TABLE 26. Anti-parasitic market, 2025 - 2032 (USD Million)
• TABLE 27. NSAIDs market, 2018 - 2024 (USD Million)
• TABLE 28. NSAIDs market, 2025 - 2032 (USD Million)
• TABLE 29. Biologics market, 2018 - 2024 (USD Million)
• TABLE 30. Biologics market, 2025 - 2032 (USD Million)
• TABLE 31. Others market, 2018 - 2024 (USD Million)
• TABLE 32. Others market, 2025 - 2032 (USD Million)
• TABLE 33. Chemical based API market, 2018 - 2024 (USD Million)
• TABLE 34. Chemical based API market, 2025 - 2032 (USD Million)
• TABLE 35. Biological API market, 2018 - 2024 (USD Million)
• TABLE 36. Biological API market, 2025 - 2032 (USD Million)
• TABLE 37. Highly potent API (HPAPI) market, 2018 - 2024 (USD Million)
• TABLE 38. Highly potent API (HPAPI) market, 2025 - 2032 (USD Million)
• TABLE 39. CDMO market, 2018 - 2024 (USD Million)
• TABLE 40. CDMO market, 2025 - 2032 (USD Million)
• TABLE 41. CMO market, 2018 - 2024 (USD Million)
• TABLE 42. CMO market, 2025 - 2032 (USD Million)
• TABLE 43. Prescription market, 2018 - 2024 (USD Million)
• TABLE 44. Prescription market, 2025 - 2032 (USD Million)
• TABLE 45. OTC market, 2018 - 2024 (USD Million)
• TABLE 46. OTC market, 2025 - 2032 (USD Million)
• TABLE 47. North America veterinary active pharmaceutical ingredients market, by country, 2018 - 2024, (USD Million)
• TABLE 48. North America veterinary active pharmaceutical ingredients market, by country, 2025 - 2032, (USD Million)
• TABLE 49. North America veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 50. North America veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 51. North America veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 52. North America veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 53. North America veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 54. North America veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 55. North America veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 56. North America veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 57. U.S. veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 58. U.S. veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 59. U.S. veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 60. U.S. veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 61. U.S. veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 62. U.S. veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 63. U.S. veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 64. U.S. veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 65. Canada veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 66. Canada veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 67. Canada veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 68. Canada veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 69. Canada veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 70. Canada veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 71. Canada veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 72. Canada veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 73. Europe veterinary active pharmaceutical ingredients market, by country, 2018 - 2024, (USD Million)
• TABLE 74. Europe veterinary active pharmaceutical ingredients market, by country, 2025 - 2032, (USD Million)
• TABLE 75. Europe veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 76. Europe veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 77. Europe veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 78. Europe veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 79. Europe veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 80. Europe veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 81. Europe veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 82. Europe veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 83. Germany veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 84. Germany veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 85. Germany veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 86. Germany veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 87. Germany veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 88. Germany veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 89. Germany veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 90. Germany veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 91. UK veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 92. UK veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 93. UK veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 94. UK veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 95. UK veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 96. UK veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 97. UK veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 98. UK veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 99. France veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 100. France veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 101. France veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 102. France veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 103. France veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 104. France veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 105. France veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 106. France veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 107. Spain veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 108. Spain veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 109. Spain veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 110. Spain veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 111. Spain veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 112. Spain veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 113. Spain veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 114. Spain veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 115. Italy veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 116. Italy veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 117. Italy veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 118. Italy veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 119. Italy veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 120. Italy veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 121. Italy veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 122. Italy veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 123. Asia Pacific veterinary active pharmaceutical ingredients market, by country, 2018 - 2024, (USD Million)
• TABLE 124. Asia Pacific veterinary active pharmaceutical ingredients market, by country, 2025 - 2032, (USD Million)
• TABLE 125. Asia Pacific veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 126. Asia Pacific veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 127. Asia Pacific veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 128. Asia Pacific veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 129. Asia Pacific veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 130. Asia Pacific veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 131. Asia Pacific veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 132. Asia Pacific veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 133. China veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 134. China veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 135. China veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 136. China veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 137. China veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 138. China veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 139. China veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 140. China veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 141. Japan veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 142. Japan veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 143. Japan veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 144. Japan veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 145. Japan veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 146. Japan veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 147. Japan veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 148. Japan veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 149. India veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 150. India veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 151. India veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 152. India veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 153. India veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 154. India veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 155. India veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 156. India veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 157. Australia veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 158. Australia veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 159. Australia veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 160. Australia veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 161. Australia veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 162. Australia veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 163. Australia veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 164. Australia veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 165. South Korea veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 166. South Korea veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 167. South Korea veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 168. South Korea veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 169. South Korea veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 170. South Korea veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 171. South Korea veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 172. South Korea veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 173. Latin America veterinary active pharmaceutical ingredients market, by country, 2018 - 2024, (USD Million)
• TABLE 174. Latin America veterinary active pharmaceutical ingredients market, by country, 2025 - 2032, (USD Million)
• TABLE 175. Latin America veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 176. Latin America veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 177. Latin America veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 178. Latin America veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 179. Latin America veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 180. Latin America veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 181. Latin America veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 182. Latin America veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 183. Brazil veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 184. Brazil veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 185. Brazil veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 186. Brazil veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 187. Brazil veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 188. Brazil veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 189. Brazil veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 190. Brazil veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 191. Mexico veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 192. Mexico veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 193. Mexico veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 194. Mexico veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 195. Mexico veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 196. Mexico veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 197. Mexico veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 198. Mexico veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 199. Argentina veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 200. Argentina veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 201. Argentina veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 202. Argentina veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 203. Argentina veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 204. Argentina veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 205. Argentina veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 206. Argentina veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 207. MEA veterinary active pharmaceutical ingredients market, by country, 2018 - 2024, (USD Million)
• TABLE 208. MEA veterinary active pharmaceutical ingredients market, by country, 2025 - 2032, (USD Million)
• TABLE 209. MEA veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 210. MEA veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 211. MEA veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 212. MEA veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 213. MEA veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 214. MEA veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 215. MEA veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 216. MEA veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 217. South Africa veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 218. South Africa veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 219. South Africa veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 220. South Africa veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 221. South Africa veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 222. South Africa veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 223. South Africa veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 224. South Africa veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 225. Saudi Arabia veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 226. Saudi Arabia veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 227. Saudi Arabia veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 228. Saudi Arabia veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 229. Saudi Arabia veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 230. Saudi Arabia veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 231. Saudi Arabia veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 232. Saudi Arabia veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 233. UAE veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 234. UAE veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 235. UAE veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 236. UAE veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 237. UAE veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 238. UAE veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 239. UAE veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 240. UAE veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)

Charts & Figures

• FIG. 1 GMI report coverage: Critical research elements
• FIG. 2 Industry segmentation
• FIG. 3 Top-down approach
• FIG. 4 Market estimation and forecast methodology
• FIG. 5 Market forecasting methodology
• FIG. 6 Breakdown of primary participants
• FIG. 7 Veterinary active pharmaceutical ingredients industry 360 degree synopsis, 2018 - 2032
• FIG. 8 Industry landscape, 2018 - 2032 (USD Million)
• FIG. 9 Growth potential analysis, by therapeutic category
• FIG. 10 Growth potential analysis, by synthesis type
• FIG. 11 Growth potential analysis, by contract outsourcing type
• FIG. 12 Growth potential analysis, by drug type
• FIG. 13 Supply chain based on traditional veterinary API manufacturing
• FIG. 14 Porter's analysis
• FIG. 15 PESTEL analysis
• FIG. 16 Company matrix analysis, 2021
• FIG. 17 Strategy dashboard, 2021